Founders Capital Management - LISATA THERAPEUTICS INC ownership

LISATA THERAPEUTICS INC's ticker is and the CUSIP is 128058302. A total of 25 filers reported holding LISATA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Founders Capital Management ownership history of LISATA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$909
-36.2%
333
-50.0%
0.00%0.0%
Q3 2023$1,425
-42.2%
6660.0%0.00%
-50.0%
Q2 2023$2,464
+123100.0%
6660.0%0.00%0.0%
Q1 2023$20.0%6660.0%0.00%0.0%
Q4 2022$2
-99.9%
6660.0%0.00%0.0%
Q3 2022$3,0006660.00%
Other shareholders
LISATA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 243,839$521,8150.48%
COOK WEALTH MANAGEMENT GROUP LLC 12,175$25,0800.02%
Founders Capital Management 666$1,4250.00%
ROYAL BANK OF CANADA 52$00.00%
VANGUARD GROUP INC 176,139$376,9380.00%
UBS Group AG 143$3060.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 20$430.00%
IFP Advisors, Inc 10$210.00%
OSAIC HOLDINGS, INC. 2$40.00%
FMR LLC 0$00.00%
View complete list of LISATA THERAPEUTICS INC shareholders